References
Hashimoto T, Tsuruta D, Koga H, et al. Summary of results of serological tests and diagnoses for 4774 cases of various autoimmune bullous diseases consulted to Kurume University. Br J Dermatol 2016; 175: 953–65.
Hayakawa T, Teye K, Hachiya T, et al. Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: Restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins. Eur J Dermatol 2016; 26: 155–63.
Izumi K, Nishie W, Mai Y, et al. Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid. J Invest Dermatol 2016; 136: 2201–10.
Salemme A, Fania L, Scarabello A, et al. Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: results of a multicenter study. J Am Acad Dermatol 2022; 87: 56–63.
Hayashi M, Tsunoda T, Sato F, et al. Clinical and immunological characterization of 14 cases of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a single-centre study. Br J Dermatol 2020; 182: 806–7.
Hashimoto T, Tsuruta D, Yasukochi A, et al. Granular C3 dermatosis. Acta Derm Venereol 2016; 96: 748–53.
Hashimoto T, Tsunoda T, Sato F, et al. Two cases of granular C3 dermatosis with intraepidermal neutrophilic and eosinophilic infiltration possibly induced by anti-hypertensive drugs. Australas J Dermatol 2021; 62: e363–5.
Izumi K, Nishie W, Mai Y, et al. Detection of mucous membrane pemphigoid autoantibodies by full-length BP180 enzyme-linked immunosorbent assay. J Dermatol Sci 2017; 88: 247–8.
Makita E, Matsuzaki Y, Fukui T, et al. Autoantibodies to BPAG1e trigger experimental bullous pemphigoid in mice. J Invest Dermatol 2021; 141: 1167–76.
Dainichi T, Kaku Y, Izumi M, et al. Anti-BP230-type papular non-bullous pemphigoid with granular immunoglobulin G deposition at the papillary dermis. J Dermatol 2021; 48: E517–9.
Acknowledgements and disclosures
Acknowledgements: We are grateful to the patient for her participation We thank Ms. Mayumi Tamada, Ms. Kyoko Hiromatsu and Ms. Yoshiko Sakamoto at Kurume University and Ms. Nami Ikeshita at Hokkaido University for their technical work. The patient in this manuscript has given written informed consent to publication of her case details. Funding sources: This study was supported in part by “Research on Measures for Intractable Diseases” Project: matching fund subsidy to Takashi Hashimoto from the Ministry of Health, Labor and Welfare. Conflicts of interest: none.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hashimoto, T., Tsunoda, T., Arai, Y. et al. A case of dipeptidyl peptidase-4 inhibitor-related anti-BP230-type bullous pemphigoid showing granular C3 dermatosis-like direct immunofluorescence staining. Eur J Dermatol 32, 549–551 (2022). https://doi.org/10.1684/ejd.2022.4316
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2022.4316